LIPID HANDLING CONVEYS SENSITIVITY TO ANTI-BCMA IMMUNOTHERAPY IN MULTIPLE MYELOMA

被引：0
|
作者：
La Spina, E. [1 ]
Romano, A. [3 ]
Giallongo, C. [2 ]
Tibullo, D. [1 ]
Dulcamare, I.
Scuderi, E. [1 ]
Scandura, G. [3 ]
Cambria, D. [3 ]
Cortellino, S. [5 ]
Mecca, M. [5 ]
Picerno, S. [5 ]
Neri, A.
Amoresano, A. [4 ]
Pinto, G. [4 ]
Serpico, S. [4 ]
Sgambato, A.
Palumbo, G. A. [2 ]
Di Raimondo, F. [3 ]
机构：
[1] Univ Catania, Dept Biotechnol & Biomed Sci, Catania, Italy
[2] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy
[3] Univ Catania, Dept Surg & Med Specialties, Catania, Italy
[4] Univ Naples Federico II, Dept Chem Sci, Naples, Italy
[5] IRCCS, Referral Canc Ctr Basilicata, Lab Preclin & Translat Res, CROB, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P094
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [31] Anti-BCMA bispecific tool therapy against Vk*MYC multiple myeloma is enhanced by IMiDs
    Meermeier, Erin W.
    Sharik, Meaghen E.
    Welsh, Seth J.
    Stein, Caleb K.
    Garbitt, Victoria M.
    Brown, Sochilt
    Todd, Kennedi T.
    Bergsagel, Marco
    Bergsagel, P. Leif
    Chesi, Marta
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Beyond BCMA: Outcomes of relapsed/refractory multiple myeloma after progression on anti-BCMA T cell redirecting therapy.
    Arora, Sankalp
    Giri, Smith
    Godby, Kelly Nicole
    Ravi, Gayathri
    Costa, Luciano J.
    Bal, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
    Singh, Vaishnavi
    Master, Samip
    BLOOD, 2023, 142
  • [34] Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
    Puertas, Borja
    Mateos, Maria-Victoria
    Gonzalez-Calle, Veronica
    HEMASPHERE, 2022, 6 (03):
  • [35] BCMA-targeted immunotherapy for multiple myeloma
    Yu, Bo
    Jiang, Tianbo
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [36] BCMA-targeted immunotherapy for multiple myeloma
    Bo Yu
    Tianbo Jiang
    Delong Liu
    Journal of Hematology & Oncology, 13
  • [37] Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance
    De Novellis, Danilo
    Fontana, Raffaele
    Giudice, Valentina
    Serio, Bianca
    Selleri, Carmine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [38] Early infections in myeloma patients treated with anti-BCMA bispecific antibodies
    Radocha, Jakub
    Pour, Ludek
    Jelinek, Tomas
    Minarik, Jiri
    Jungova, Alexandra
    Novakova, Denisa
    Stork, Martin
    Muronova, Ludmila
    Pika, Tomas
    Hajek, Roman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S57 - S58
  • [39] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    D'Agostino, Mattia
    Raje, Noopur
    LEUKEMIA, 2020, 34 (01) : 21 - 34
  • [40] Anti-BCMA CAR T-cell Therapy Reins in Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (07) : 817 - 819
12345